Factbook>Countries>Japan>Demographics HIV/AIDS - adult prevalence rate:<.1% (2020 est.) Definition:This entry gives an estimate of the percentage of adults (aged 15-49) living with HIV/AIDS. The adult prevalence rate is calculated by dividing the estimated number of adults living with HIV/AID...
type I error ratecategorical variablesmeasurement errorconfoundingepidemologic methodsSixty-one Japanese with sexually transmitted HIV were investigated to clarify the state of, and difficulties in, their sexual activities and social relationships. The study revealed the following difficulties in social ...
In left panel, percentage of productively or latently cells relative to the total infection rate (bars) and total cell viability (blue dotted line) of a representative experiment. In the right panel, ratios of productive versus latent populations relative to the total infection rate upon increasing...
Gilead worked with Japan Tobacco on the HIV integrase inhibitor elvitegravir (Vitekta, 2014). Regrettably, despite being a potent integrase strand transfer inhibitor (INSTI), elvitegravir was extensively metabolized, primarily b...
Without new interventions amongst MSM in Japan, HIV prevalence will climb from its current rate of 2.1% to 10.4% (sensitivity range 7.4% to 18.7%), while HIV prevalence among low-risk men and women will likely decline. With small changes in safer sex behavior and testing rates, HIV ...
Pathological status and therapy of HIV-infected hemophiliacs in Japan. In Japan, 1531 out of 4171 hemophiliacs (36.7%) are human immunodeficiency virus (HIV)-infected, and up to 31 December 1991, 324 (21.2%) of these patients ...
Currently, there is limited information available on the impact of the COVID-19 pandemic on PLHIV in Venezuela. Additionally, the rate of COVID-19 vaccine hesitancy among this population is unknown. This study aims to assess the impact of the COVID-19 pandemic and COVID-19 vaccine hesitancy...
Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann. Intern. Med. 118, 681–688 (1993). CAS PubMed Google Scholar Jekle, A. et al. In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity ...
including the latest and the best darunavir, need to be given with a pharmacokinetic enhancer such as ritonavir or cobicistat in order to achieve effective plasma drug levels at the desired dose and frequency. Gratifyingly, the availability of protease inhibit...
Mississippi in group of states highly impacted by HIV/AIDS The state’s HIV prevalence rate stands at 466 cases per 100,000 people. Hinds County is among the top five counties in the state for new diagnoses. When you look at the numbers by race, Black Mississippians continue to be dispropo...